278 related articles for article (PubMed ID: 22316156)
1. Computational insights for the discovery of non-ATP competitive inhibitors of MAP kinases.
Schnieders MJ; Kaoud TS; Yan C; Dalby KN; Ren P
Curr Pharm Des; 2012; 18(9):1173-85. PubMed ID: 22316156
[TBL] [Abstract][Full Text] [Related]
2. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ
ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814
[TBL] [Abstract][Full Text] [Related]
3. Discovery and Characterization of a Biologically Active Non-ATP-Competitive p38 MAP Kinase Inhibitor.
Wilson BA; Alam MS; Guszczynski T; Jakob M; Shenoy SR; Mitchell CA; Goncharova EI; Evans JR; Wipf P; Liu G; Ashwell JD; O'Keefe BR
J Biomol Screen; 2016 Mar; 21(3):277-89. PubMed ID: 26538432
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of bi-thiazole-2,2'-diamines as kinase inhibitory scaffolds.
Ngoei KR; Ng DC; Gooley PR; Fairlie DP; Stoermer MJ; Bogoyevitch MA
Biochim Biophys Acta; 2013 Jun; 1834(6):1077-88. PubMed ID: 23410953
[TBL] [Abstract][Full Text] [Related]
5. Mitogen activated protein (MAP) kinases: development of ATP and non-ATP dependent inhibitors.
Hancock CN; Macias AT; Mackerell AD; Shapiro P
Med Chem; 2006 Mar; 2(2):213-22. PubMed ID: 16787369
[TBL] [Abstract][Full Text] [Related]
6. Pocketome of human kinases: prioritizing the ATP binding sites of (yet) untapped protein kinases for drug discovery.
Volkamer A; Eid S; Turk S; Jaeger S; Rippmann F; Fulle S
J Chem Inf Model; 2015 Mar; 55(3):538-49. PubMed ID: 25557645
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in designing substrate-competitive protein kinase inhibitors.
Han KC; Kim SY; Yang EG
Curr Pharm Des; 2012; 18(20):2875-82. PubMed ID: 22571656
[TBL] [Abstract][Full Text] [Related]
8. Conformation-selective ATP-competitive inhibitors control regulatory interactions and noncatalytic functions of mitogen-activated protein kinases.
Hari SB; Merritt EA; Maly DJ
Chem Biol; 2014 May; 21(5):628-35. PubMed ID: 24704509
[TBL] [Abstract][Full Text] [Related]
9. Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket.
Gum RJ; McLaughlin MM; Kumar S; Wang Z; Bower MJ; Lee JC; Adams JL; Livi GP; Goldsmith EJ; Young PR
J Biol Chem; 1998 Jun; 273(25):15605-10. PubMed ID: 9624152
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of inhibitor selectivity in MAP kinases.
Wang Z; Canagarajah BJ; Boehm JC; Kassisà S; Cobb MH; Young PR; Abdel-Meguid S; Adams JL; Goldsmith EJ
Structure; 1998 Sep; 6(9):1117-28. PubMed ID: 9753691
[TBL] [Abstract][Full Text] [Related]
11. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
[TBL] [Abstract][Full Text] [Related]
12. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
13. Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides.
Schirmer A; Kennedy J; Murli S; Reid R; Santi DV
Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4234-9. PubMed ID: 16537514
[TBL] [Abstract][Full Text] [Related]
14. CCAAT/enhancer-binding protein and activator protein-1 transcription factors regulate the expression of interleukin-8 through the mitogen-activated protein kinase pathways in response to mechanical stretch of human airway smooth muscle cells.
Kumar A; Knox AJ; Boriek AM
J Biol Chem; 2003 May; 278(21):18868-76. PubMed ID: 12637525
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of p38 MAP kinase as a therapeutic strategy.
Lee JC; Kumar S; Griswold DE; Underwood DC; Votta BJ; Adams JL
Immunopharmacology; 2000 May; 47(2-3):185-201. PubMed ID: 10878289
[TBL] [Abstract][Full Text] [Related]
16. Designing an orally available nontoxic p38 inhibitor with a fragment-based strategy.
Guarnieri F
Methods Mol Biol; 2015; 1289():211-26. PubMed ID: 25709042
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced proliferative response of vascular adventitial fibroblasts is dependent on g protein-mediated activation of mitogen-activated protein kinases.
Das M; Bouchey DM; Moore MJ; Hopkins DC; Nemenoff RA; Stenmark KR
J Biol Chem; 2001 May; 276(19):15631-40. PubMed ID: 11278727
[TBL] [Abstract][Full Text] [Related]
18. Recent advances of MEK inhibitors and their clinical progress.
Wang JY; Wilcoxen KM; Nomoto K; Wu S
Curr Top Med Chem; 2007; 7(14):1364-78. PubMed ID: 17692026
[TBL] [Abstract][Full Text] [Related]
19. Acrolein activates mitogen-activated protein kinase signal transduction pathways in rat vascular smooth muscle cells.
Ranganna K; Yousefipour Z; Nasif R; Yatsu FM; Milton SG; Hayes BE
Mol Cell Biochem; 2002 Nov; 240(1-2):83-98. PubMed ID: 12487375
[TBL] [Abstract][Full Text] [Related]
20. In the cellular garden of forking paths: how p38 MAPKs signal for downstream assistance.
Shi Y; Gaestel M
Biol Chem; 2002 Oct; 383(10):1519-36. PubMed ID: 12452429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
